KUANGCHI SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.56 HKD | +1.82% |
|
-6.67% | -45.10% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,078 | 1,755 | 3,325 | 1,231 | 720.4 | 628 |
| Enterprise Value (EV) 1 | 3,115 | 2,015 | 3,675 | 1,067 | 672.3 | 477.8 |
| P/E ratio | -6.73 x | -5.96 x | -42.4 x | -30.3 x | -10.6 x | -86.1 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 19.4 x | 28.9 x | 33.4 x | 10.8 x | 13.7 x | 7.55 x |
| EV / Revenue | 19.7 x | 33.1 x | 36.9 x | 9.36 x | 12.8 x | 5.75 x |
| EV / EBITDA | -8.12 x | -10.3 x | -71.9 x | -27.7 x | -14.1 x | -30.9 x |
| EV / FCF | -8.03 x | -40.3 x | -428 x | 16 x | -8.78 x | -6.45 x |
| FCF Yield | -12.4% | -2.48% | -0.23% | 6.23% | -11.4% | -15.5% |
| Price to Book | 2.21 x | 1.71 x | 1.72 x | 0.55 x | 0.45 x | 0.42 x |
| Nbr of stocks (in thousands) | 615,693 | 615,693 | 615,693 | 615,693 | 615,693 | 615,693 |
| Reference price 2 | 5.000 | 2.850 | 5.400 | 2.000 | 1.170 | 1.020 |
| Announcement Date | 4/30/19 | 5/13/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/29/24 |
1HKD in Million2HKD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 158.4 | 60.82 | 99.48 | 114 | 52.52 | 83.14 |
| EBITDA 1 | -383.8 | -194.7 | -51.14 | -38.48 | -47.83 | -15.46 |
| EBIT 1 | -400 | -210 | -60.07 | -46.22 | -53.46 | -20.34 |
| Operating Margin | -252.5% | -345.25% | -60.39% | -40.55% | -101.79% | -24.46% |
| Earnings before Tax (EBT) 1 | -430 | -293.1 | -77.22 | -40.61 | -67.91 | -7.295 |
| Net income 1 | -457.6 | -294.4 | -78.35 | -40.61 | -67.91 | -7.295 |
| Net margin | -288.88% | -484.09% | -78.76% | -35.63% | -129.3% | -8.77% |
| EPS 2 | -0.7432 | -0.4782 | -0.1273 | -0.0660 | -0.1103 | -0.0118 |
| Free Cash Flow 1 | -387.8 | -49.96 | -8.579 | 66.47 | -76.59 | -74.08 |
| FCF margin | -244.83% | -82.13% | -8.62% | 58.32% | -145.83% | -89.1% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/19 | 5/13/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/29/24 |
1HKD in Million2HKD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 36.8 | 260 | 350 | - | - | - |
| Net Cash position 1 | - | - | - | 165 | 48.1 | 150 |
| Leverage (Debt/EBITDA) | -0.096 x | -1.337 x | -6.847 x | - | - | - |
| Free Cash Flow 1 | -388 | -50 | -8.58 | 66.5 | -76.6 | -74.1 |
| ROE (net income / shareholders' equity) | -21.9% | -23.6% | -5.17% | -1.95% | -3.54% | -0.47% |
| ROA (Net income/ Total Assets) | -9.12% | -6.58% | -1.6% | -1.03% | -1.41% | -0.67% |
| Assets 1 | 5,018 | 4,477 | 4,889 | 3,946 | 4,826 | 1,093 |
| Book Value Per Share 2 | 2.260 | 1.660 | 3.150 | 3.610 | 2.630 | 2.430 |
| Cash Flow per Share 2 | 0.7000 | 0.4000 | 0.2400 | 0.4800 | 0.2600 | 0.4200 |
| Capex 1 | 123 | 62.4 | 14 | 21.9 | 14.9 | 9.08 |
| Capex / Sales | 77.72% | 102.64% | 14.09% | 19.24% | 28.39% | 10.92% |
| Announcement Date | 4/30/19 | 5/13/20 | 4/28/21 | 4/28/22 | 4/27/23 | 4/29/24 |
1HKD in Million2HKD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -45.10% | 44.14M | |
| -17.81% | 181B | |
| +1.85% | 169B | |
| +3.95% | 156B | |
| +8.31% | 103B | |
| +36.74% | 84.96B | |
| +13.15% | 83.78B | |
| -2.69% | 76.05B | |
| -3.40% | 46.42B | |
| -34.07% | 43.93B |
- Stock Market
- Equities
- 439 Stock
- Financials KuangChi Science Limited
